Medical specialists from France tagged as investigators in clinical trials studying Esophageal Diseases

Total 5 results

Gilles Lebreton, MD, PhD
Seen in:
- Caen, Chu de Caen Normandie
Trials:
- NCT02526095 (Principal Investigator)
Conditions:
- Esophageal Disease
Marie-Pierre Galais, MD,PhD
Seen in:
- Caen, Crlcc Francois Baclesse
Trials:
- NCT02526095 (Principal Investigator)
Conditions:
- Esophageal Disease
Muriel Mathonnet, Md,PhD
Seen in:
- Limoges, C H U Dupuytren Limoges
Trials:
- NCT02526095 (Principal Investigator)
Conditions:
- Esophageal Disease
Sabine ROMAN, MD, PhD
Seen in:
- LYON cedex 03, Exploration Fonctionnelle Digestive, Hôpital Edouard Herriot
Trials:
- NCT02905669 (Principal Investigator)
Conditions:
- Esophageal Dysfunction;
- Pylorus Dysfunction
Xavier Mirabelle, MD,PhD
Seen in:
- Lille, Clcc Oscar Lambret Lille
Trials:
- NCT02526095 (Principal Investigator)
Conditions:
- Esophageal Disease

Clinical Trials on Esophageal Diseases

Johns Hopkins University

Withdrawn

Esophageal Stent Migration With Endoscopic Suture Fixation Compared to Standard Deployment

Esophageal Perforation | Esophageal Fistula | Esophageal Strictures | Esophageal Leak | Endostitch | Esophageal Stent

United States
Federal University of São Paulo

Unknown

Evaluation of Topical Mitomycin C as Adjuvant Drug to Esophageal Dilation in Children

Esophageal Stricture | Caustic Esophageal Stricture | Peptic Esophageal Stricture | Post-Surgical Esophageal Stricture

Brazil
Istituto Clinico Humanitas

Recruiting

Clinical Efficacy and Safety of Endoscopic Dilatation With Eso-Filp in Benign Esophageal Strictures (ESO-FLIP)

Esophageal Cancer

Italy
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Terminated

Molecular Phenotyping in Predicting Response in Patients With Stage IB-III Esophageal Cancer Receiving Combination Chemotherapy

Stage IIIA Esophageal Adenocarcinoma | Stage IIIB Esophageal Adenocarcinoma | Stage IIIC Esophageal Adenocarcinoma | Stage IIB Esophageal Adenocarcinoma | Stage IB Esophageal Adenocarcinoma | Stage IIA Esophageal Adenocarcinoma

United States
Mayo Clinic

Recruiting

Effect of Opioid Cessation on Opioid-Induced Esophageal Dysfunction

Opioid-Induced Esophageal Dysfunction

United States
University Hospital, Lille
Federation of Research in Surgery (FRENCH); French Eso-Gastric Tumors Working... and other collaborators

Completed

Outcomes After Esophageal Cancer Surgery (FREGAT I)

Esophageal Neoplasm | Esophageal Disease

France
Mayo Clinic

Completed

Outcomes of Esophageal Self Dilation for Benign Refractory Esophageal Stricture Management

Esophageal Dilation | Refractory Benign Esophageal Stricture

United States
OHSU Knight Cancer Institute
Oregon Health and Science University

Withdrawn

Ferumoxytol-Enhanced MRI in Imaging Lymph Nodes in Patients With Stage IIB-IIIC Esophageal Cancer

Stage IIB Esophageal Cancer AJCC v7 | Stage III Esophageal Cancer AJCC v7 | Stage IIIA Esophageal Cancer AJCC v7 | Stage IIIB Esophageal Cancer AJCC v7 | Stage IIIC Esophageal Cancer AJCC v7
University of Michigan Rogel Cancer Center
Genentech, Inc.

Terminated

Phase II Trial for Patients With Loco-Regional Esophageal Carcinoma

Loco-regional Esophageal Cancer
Mayo Clinic

Terminated

Achalasia Patient Reported Outcomes

Achalasia | Esophageal Achalasia | Achalasia, Esophageal

United States

Medical specialists from France tagged as investigators in clinical trials studying Esophageal Diseases

Clinical Trials on Esophageal Diseases

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations